HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

nimotuzumab

a humanized monoclonal antibody for epidermal growth factor receptor for treatment of cancers of epithelial origin, such as breast, lung, head and neck, and pancreatic cancer
Networked: 96 relevant articles (22 outcomes, 42 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Crombet, Tania: 8 articles (01/2015 - 01/2009)
2. Bach, Ferdinand: 4 articles (03/2015 - 12/2012)
3. Saurez, Giselle: 4 articles (05/2014 - 01/2009)
4. Montero, Enrique: 4 articles (10/2012 - 12/2007)
5. Iznaga, Normando: 4 articles (02/2011 - 07/2009)
6. Fan, Min: 3 articles (07/2015 - 08/2012)
7. Massimino, Maura: 3 articles (06/2014 - 02/2011)
8. Bode, Udo: 3 articles (06/2014 - 02/2011)
9. Alert, José: 3 articles (05/2014 - 03/2010)
10. Cabanas, Ricardo: 3 articles (05/2014 - 07/2009)

Related Diseases

1. Neoplasms (Cancer)
2. Glioma (Gliomas)
3. Carcinoma (Carcinomatosis)
4. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
5. Pancreatic Neoplasms (Pancreatic Cancer)

Related Drugs and Biologics

1. Epidermal Growth Factor Receptor (EGF Receptor)
2. Cisplatin (Platino)
3. docetaxel (Taxotere)
4. Carboplatin (JM8)
5. cetuximab (Erbitux)
6. Fluorouracil (Carac)
7. Epidermal Growth Factor (EGF)
8. gemcitabine
9. Sirolimus (Rapamycin)
10. capecitabine (Xeloda)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Radiotherapy
3. Heterologous Transplantation (Xenotransplantation)
4. Photochemotherapy (Photodynamic Therapy)
5. Brachytherapy